Rapid antigen test had up to 98% sensitivity and 100% specificity for detecting COVID-19 in persons with mild symptoms
- PMID: 34058108
- DOI: 10.7326/ACPJ202106150-071
Rapid antigen test had up to 98% sensitivity and 100% specificity for detecting COVID-19 in persons with mild symptoms
Abstract
Gremmels H, Winkel BMF, Schuurman R, et al. Real-life validation of the Panbio COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection. EClinicalMedicine. 2021;31:100677. 33521610.
Comment on
-
Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection.EClinicalMedicine. 2021 Jan;31:100677. doi: 10.1016/j.eclinm.2020.100677. Epub 2020 Dec 5. EClinicalMedicine. 2021. PMID: 33521610 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous